EBRD exits Ibnsina Pharma, sells 8.8% stake on Egyptian Exchange
The European Bank for Reconstruction and Development (EBRD) has fully exited its remaining 8.8% stake in Ibnsina Pharma through the Egyptian Exchange (EGX). EBRD initially acquired a 20% stake in Ibnsina Pharma in 2015, supporting the company’s development by financing
0 Comments